Look-alike/sound-alike (LASA) medications pose asignificant risk of medication errors. To reduce this risk, pharmacies should:
* Use both brand and generic nameson labels to clarify drug identity.
* Example:"Celexa (Citalopram)" vs. "Celebrex (Celecoxib)."
* B. Place the drug next to another look-alike/sound-alike drug on the shelf if they are alphabetical.
##Incorrect
* LASA drugs shouldnotbe stored next to each other.
* Example:Hydroxyzine and Hydralazine should be stored separatelyto avoid mix-ups.
* C. Review the first five digits of the NDC to confirm the correct product.##Incorrect
* The first five digits (manufacturer code) only identify the manufacturer, not the specific drug.
* Instead, checking theentire NDC (all 10-11 digits) is necessary.
* D. Take hazardous drug precautions.##Incorrect
* LASA errors are a labeling issue, not a hazardous drug issue.
* Institute for Safe Medication Practices (ISMP) LASA Guidelines- Recommends usingboth brand and generic names on labels.
* FDA & Joint Commission LASA Drug Safety Recommendations- Emphasizes labeling improvements for LASA drugs.
* PTCB PTCE Exam Content Outline- Covers medication safety and error prevention strategies.
Why Not the Other Options?Key References: